Current diagnosis and management of post-transjugular intrahepatic portosystemic shunt refractory hepatic encephalopathy

Keith Pereira, Andres F. Carrion, Paul Martin, Kirubahara Vaheesan, Jason Salsamendi, Mehul Doshi, Jose Yrizarry

Research output: Contribution to journalReview article

22 Citations (Scopus)

Abstract

Transjugular intrahepatic portosystemic shunt has evolved into an important option for management of complications of portal hypertension. The use of polytetrafluoroethylene covered stents enhances shunt patency. Hepatic encephalopathy (HE) remains a significant problem after TIPS placement. The approach to management of patients with refractory hepatic encephalopathy typically requires collaboration between different specialties. Patient selection for TIPS requires careful evaluation of risk factors for HE. TIPS procedure-related technical factors like stent size, attention to portosystemic pressure gradient reduction and use of adjunctive variceal embolization maybe important. Conservative medical therapy in combination with endovascular therapies often results in resolution or substantial reduction of symptoms. Liver transplantation is, however, the ultimate treatment.

Original languageEnglish (US)
Pages (from-to)2487-2494
Number of pages8
JournalLiver International
Volume35
Issue number12
DOIs
StatePublished - Dec 1 2015

Fingerprint

Transjugular Intrahepatic Portasystemic Shunt
Hepatic Encephalopathy
Stents
Polytetrafluoroethylene
Portal Hypertension
Liver Transplantation
Patient Selection
Pressure
Therapeutics

Keywords

  • Hepatic encephalopathy
  • Portal hypertension
  • Spontaneous portosystemic shunt
  • Transjugular intrahepatic portosystemic shunt

ASJC Scopus subject areas

  • Hepatology

Cite this

Current diagnosis and management of post-transjugular intrahepatic portosystemic shunt refractory hepatic encephalopathy. / Pereira, Keith; Carrion, Andres F.; Martin, Paul; Vaheesan, Kirubahara; Salsamendi, Jason; Doshi, Mehul; Yrizarry, Jose.

In: Liver International, Vol. 35, No. 12, 01.12.2015, p. 2487-2494.

Research output: Contribution to journalReview article

Pereira, Keith ; Carrion, Andres F. ; Martin, Paul ; Vaheesan, Kirubahara ; Salsamendi, Jason ; Doshi, Mehul ; Yrizarry, Jose. / Current diagnosis and management of post-transjugular intrahepatic portosystemic shunt refractory hepatic encephalopathy. In: Liver International. 2015 ; Vol. 35, No. 12. pp. 2487-2494.
@article{036fde6bad9a4732a31ae0d4bc0baf49,
title = "Current diagnosis and management of post-transjugular intrahepatic portosystemic shunt refractory hepatic encephalopathy",
abstract = "Transjugular intrahepatic portosystemic shunt has evolved into an important option for management of complications of portal hypertension. The use of polytetrafluoroethylene covered stents enhances shunt patency. Hepatic encephalopathy (HE) remains a significant problem after TIPS placement. The approach to management of patients with refractory hepatic encephalopathy typically requires collaboration between different specialties. Patient selection for TIPS requires careful evaluation of risk factors for HE. TIPS procedure-related technical factors like stent size, attention to portosystemic pressure gradient reduction and use of adjunctive variceal embolization maybe important. Conservative medical therapy in combination with endovascular therapies often results in resolution or substantial reduction of symptoms. Liver transplantation is, however, the ultimate treatment.",
keywords = "Hepatic encephalopathy, Portal hypertension, Spontaneous portosystemic shunt, Transjugular intrahepatic portosystemic shunt",
author = "Keith Pereira and Carrion, {Andres F.} and Paul Martin and Kirubahara Vaheesan and Jason Salsamendi and Mehul Doshi and Jose Yrizarry",
year = "2015",
month = "12",
day = "1",
doi = "10.1111/liv.12956",
language = "English (US)",
volume = "35",
pages = "2487--2494",
journal = "Liver International",
issn = "1478-3223",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - Current diagnosis and management of post-transjugular intrahepatic portosystemic shunt refractory hepatic encephalopathy

AU - Pereira, Keith

AU - Carrion, Andres F.

AU - Martin, Paul

AU - Vaheesan, Kirubahara

AU - Salsamendi, Jason

AU - Doshi, Mehul

AU - Yrizarry, Jose

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Transjugular intrahepatic portosystemic shunt has evolved into an important option for management of complications of portal hypertension. The use of polytetrafluoroethylene covered stents enhances shunt patency. Hepatic encephalopathy (HE) remains a significant problem after TIPS placement. The approach to management of patients with refractory hepatic encephalopathy typically requires collaboration between different specialties. Patient selection for TIPS requires careful evaluation of risk factors for HE. TIPS procedure-related technical factors like stent size, attention to portosystemic pressure gradient reduction and use of adjunctive variceal embolization maybe important. Conservative medical therapy in combination with endovascular therapies often results in resolution or substantial reduction of symptoms. Liver transplantation is, however, the ultimate treatment.

AB - Transjugular intrahepatic portosystemic shunt has evolved into an important option for management of complications of portal hypertension. The use of polytetrafluoroethylene covered stents enhances shunt patency. Hepatic encephalopathy (HE) remains a significant problem after TIPS placement. The approach to management of patients with refractory hepatic encephalopathy typically requires collaboration between different specialties. Patient selection for TIPS requires careful evaluation of risk factors for HE. TIPS procedure-related technical factors like stent size, attention to portosystemic pressure gradient reduction and use of adjunctive variceal embolization maybe important. Conservative medical therapy in combination with endovascular therapies often results in resolution or substantial reduction of symptoms. Liver transplantation is, however, the ultimate treatment.

KW - Hepatic encephalopathy

KW - Portal hypertension

KW - Spontaneous portosystemic shunt

KW - Transjugular intrahepatic portosystemic shunt

UR - http://www.scopus.com/inward/record.url?scp=84983142885&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983142885&partnerID=8YFLogxK

U2 - 10.1111/liv.12956

DO - 10.1111/liv.12956

M3 - Review article

C2 - 26332169

AN - SCOPUS:84983142885

VL - 35

SP - 2487

EP - 2494

JO - Liver International

JF - Liver International

SN - 1478-3223

IS - 12

ER -